Results 31 to 40 of about 10,882 (150)

Colchicine in Treatment of Intractable Postpericardiotomy Syndrome in an Elderly Patient

International Journal of Gerontology, 2011
Postpericardiotomy syndrome is a specific type of acute pericarditis because of a delayed pericardial and/or pleural reaction after thoracic surgery. Relapse after aspirin, nonsteroidal anti-inflammatory drug, and/or steroid treatment or intractable to ...
Lin-Shong Li, Chun-Fu Chen, Der-Yan Tai
doaj   +1 more source

The Use of IL-1 Receptor Antagonist (Anakinra) in Idiopathic Recurrent Pericarditis: A Narrative Review

Cardiology Research and Practice, 2016
Recurrent pericarditis is a complication of acute pericarditis in 20–30% of the patients and is usually idiopathic in nature. The underlying pathogenesis of this condition remains unclear, although immune-mediated mechanisms seem likely.
Shankar Baskar, Allan L. Klein, Andrew Zeft   +2 more
doaj   +1 more source

Recurrent pericarditis: a case report and literature review

Acta Medica Lituanica, 2017
Background. Recurrence affects about 30% (20% to 50%) of patients within 18 months after the initial episode of acute pericarditis resulting in subsequent rehospitalizations.
Justina Katinaitė, Birutė Petrauskienė   +1 more
doaj   +1 more source

Meta-analysis for the value of colchicine for the therapy of pericarditis and of postpericardiotomy syndrome

BMC Cardiovascular Disorders, 2019
Background Colchicine has been used as anti-inflammatory agent in pericardial effusion (PE). We sought to perform a meta-analysis of randomized trials assessing the efficacy and safety of colchicine in patients with pericarditis or postpericardiotomy ...
Leon L. Lutschinger, Angelos G. Rigopoulos, Peter Schlattmann, Marios Matiakis, Daniel Sedding, Paul Christian Schulze, Michel Noutsias   +6 more
doaj   +1 more source

Problems of immunopathology and prospects for pharmacotherapy of idiopathic recurrent pericarditis: Using an interleukin 1 inhibitor (Anakinra)

Научно-практическая ревматология, 2023
Pericarditis, a clinical syndrome characterized by inflammation and thickening of the pericardium, is one of the most common forms of inflammatory diseases of the cardiovascular system.
E. L. Nasonov, Z. N. Sukmarova, T. V. Popkova, B. S. Belov   +3 more
doaj   +1 more source

Predictive factors of recurrence after pediatric acute pericarditis

Jornal de Pediatria, 2021
Objective: The predisposing factors for pericarditis recurrence in the pediatric population have not yet been established. This study aimed to define the risk factors for the unfavorable prognosis of pediatric acute pericarditis.
Stasa Krasic, Sergej Prijic, Sanja Ninic, Ruzica Borovic, Gordana Petrovic, Mila Stajevic, Dejan Nesic, Ivan Dizdarevic, Nemanja Djordjevic, Vladislav Vukomanovic   +9 more
doaj   +1 more source

The clinical course of patients with previous acute and recurrent pericarditis receiving the BNT162b2 vaccine

International Journal of Cardiology: Heart & Vasculature, 2022
Background: Vaccines against SARS-COV2 have been crucial in efforts against COVID19, yet there have been reports of pericarditis following vaccination with mRNA-based vaccines.
Yishay Wasserstrum, Sofia Nadav, Amitai Segev, Dor Lotan, Dov Freimark, Michael Arad   +5 more
doaj   +1 more source

Idiopathic recurrent pericarditis — a paradigm shift?

Российский кардиологический журнал, 2019
Idiopathic recurrent  pericarditis (IRP) is a relatively rare inflammatory disease of the pericardium,  often  requiring  emergency medical  care,   associated with a  high percentage of temporary  disability and  significant  economic  costs.
V. Yu. Myachikova, V. A. Titov, A. L. Maslyanskiy, O. M. Moiseeva   +3 more
doaj   +1 more source

A Rare Complication of End-stage Renal Disease: Constrictive Pericarditis

Çocuk Dergisi, 2022
End-stage renal disease (ESRD) is a devastating disease associated with cardiovascular morbidity. The prevalence of pericardial syndromes associated with ESRD is increasing because the survival of chronic renal failure (CRF) patients is prolonged ...
Cansu Ceren Eryılmaz, Emine Özlem Çam Delebe, Damla Akbulut, Zeynep Nagehan Yürük Yıldırım, Bağdagül Yavaş Aksu, Alev Yılmaz, Kemal Nişli, Ahmet Nevzat Nayır   +7 more
doaj   +1 more source

Expanding the Patient Pool for Rilonacept

JACC: Case Reports
Recurrent pericarditis complicates 15%-30% of acute pericarditis cases despite initial anti-inflammatory treatment. The RHAPSODY trial (Study to Assess the Efficacy and Safety of Rilonacept Treatment in Participants With Recurrent Pericarditis) showed ...
Emma St. John, MD, Jessica R. Carey, PharmD, Tanya Wilcox, MD, John Ryan, MD, Satvik Ramakrishna, MD, Anees Daud, MD, Denise Diaz-Robles, PA-C, Adam Smith, PharmD, Kristin Cowan, CPh-T, Libo Wang, MD   +9 more
doaj   +1 more source